The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(4-(3-(4-(1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-4-(trifluoromethyl)phenyl)piperazin-1-yl)-2-oxoethyl)acrylamide ID: ALA4513304
PubChem CID: 155538868
Max Phase: Preclinical
Molecular Formula: C28H24F3N5O4
Molecular Weight: 551.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)NCC(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1
Standard InChI: InChI=1S/C28H24F3N5O4/c1-2-22(37)33-15-23(38)36-11-9-35(10-12-36)16-7-8-20(28(29,30)31)18(13-16)24-25(27(40)34-26(24)39)19-14-32-21-6-4-3-5-17(19)21/h2-8,13-14,32H,1,9-12,15H2,(H,33,37)(H,34,39,40)
Standard InChI Key: NYTXQRHJIKPXKY-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
25.3164 -2.3072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1336 -2.3072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3879 -1.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7250 -1.0483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0662 -1.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2889 -1.2783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1655 -1.2790 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.6148 -2.9684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3614 -3.7453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0220 -4.2265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4320 -2.9694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6826 -3.7460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4788 -3.9159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0252 -3.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7699 -2.5318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9742 -2.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8357 -2.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0222 -2.8767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5411 -3.5364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8725 -4.2843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6896 -4.3686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1670 -3.7080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5834 -2.1820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1839 -1.5549 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.8518 -1.3712 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.7352 -2.0827 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.0239 -5.1136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.5429 -5.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8737 -6.5187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6865 -6.6066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1675 -5.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8357 -5.1951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0178 -7.3536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5364 -8.0140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8303 -7.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1616 -8.1873 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6802 -8.8477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0114 -9.5948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8676 -8.7610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5301 -10.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 2 0
3 7 2 0
8 9 2 0
9 10 1 0
10 12 1 0
11 8 1 0
2 8 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
1 17 1 0
23 24 1 0
23 25 1 0
23 26 1 0
18 23 1 0
27 28 1 0
27 32 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
21 27 1 0
30 33 1 0
33 34 2 0
33 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
37 39 2 0
38 40 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 551.53Molecular Weight (Monoisotopic): 551.1780AlogP: 2.70#Rotatable Bonds: 6Polar Surface Area: 114.61Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.87CX Basic pKa: 2.28CX LogP: 2.51CX LogD: 2.51Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.32Np Likeness Score: -0.73
References 1. Shi L, Zhong Z, Li X, Zhou Y, Pan Z.. (2019) Discovery of an Orally Available Janus Kinase 3 Selective Covalent Inhibitor., 62 (2): [PMID:30615446 ] [10.1021/acs.jmedchem.8b01823 ]